Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9518)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Stine JG, Shah PM, Cornella SL, Rudnick SR, Ghabril MS, Stukenborg GJ, Northup PG. Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis. World J Hepatol 2015; 7(27): 2774-2780 [PMID: 26644821 DOI: 10.4254/wjh.v7.i27.2774] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i27/2774.htm |
| Number | Citing Articles |
| 1 |
Tsai-Wing Ow, Evangelia Fatourou, Liane Rabinowich, Bente van den Boom, Shrijit Nair, Vishal C. Patel, Brian Hogan, Mark McPhail, Lara N. Roberts, William Bernal. Prevalence of Bleeding and Thrombosis in Critically Ill Patients with Chronic Liver Disease. Thrombosis and Haemostasis 2022; 122(06): 1006 doi: 10.1055/a-1667-7293
|
| 2 |
Dong-Jie Yang, Yu-Yong Tan, He-Jun Zhou, Chen-Jie Li. Anticoagulation therapy for portal vein thrombosis in patients with liver cirrhosis. World Chinese Journal of Digestology 2023; 31(13): 562 doi: 10.11569/wcjd.v31.i13.562
|
| 3 |
Swathi Prakash, Jared Bies, Mariam Hassan, Adriana Mares, S. Claudia Didia. Portal vein thrombosis in cirrhosis: A literature review. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1134801
|
| 4 |
Jonathan G. Stine, Jennifer Wang, Puja M. Shah, Curtis K. Argo, Nicolas Intagliata, Andre Uflacker, Stephen H. Caldwell, Patrick G. Northup. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case‐control study. Liver International 2018; 38(1): 94 doi: 10.1111/liv.13500
|
| 5 |
Jiahui Pan, Le Wang, Fangbo Gao, Yang An, Yue Yin, Xiaozhong Guo, Filipe Gaio Nery, Eric M. Yoshida, Xingshun Qi. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis. European Journal of Internal Medicine 2022; 104: 21 doi: 10.1016/j.ejim.2022.05.032
|
| 6 |
Guo-Le Nie, Jun Yan, Ying Li, Hong-Long Zhang, Dan-Na Xie, Xing-Wang Zhu, Xun Li. Predictive model for non-malignant portal vein thrombosis associated with cirrhosis based on inflammatory biomarkers. World Journal of Gastrointestinal Oncology 2024; 16(4): 1213-1226 doi: 10.4251/wjgo.v16.i4.1213
Abstract(220) |
Core Tip(228) |
Full Article(HTML)(808)
|
Full Article with Cover (PDF)-2130K(115)
|
Audio-1077K(3)
|
Peer-Review Report-169K(31)
|
Answering Reviewers-104K(25)
|
Supplementary Material-93K(31)
|
Full Article (PDF)-1902K(51)
|
Full Article (XML)-124K(24)
|
Times Cited (2)
|
Total Visits (2652)
|
Open
|
| 7 |
Dominique-Charles Valla, Dominique Cazals-Hatem. Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts. Virchows Archiv 2018; 473(1): 3 doi: 10.1007/s00428-018-2331-3
|
| 8 |
Stefania Basili, Daniele Pastori, Valeria Raparelli, Francesco Violi. Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818793561
|
| 9 |
Douglas A. Simonetto, Ashwani K. Singal, Guadalupe Garcia-Tsao, Stephen H. Caldwell, Joseph Ahn, Patrick S. Kamath. ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation. American Journal of Gastroenterology 2020; 115(1): 18 doi: 10.14309/ajg.0000000000000486
|
| 10 |
Nicoletta Riva, Walter Ageno. Timing of anticoagulation for portal vein thrombosis in liver cirrhosis: An Italian internist’s perspective. Journal of Translational Internal Medicine 2018; 6(1): 6 doi: 10.2478/jtim-2018-0002
|
| 11 |
Marco Senzolo, Sarah Shalaby, Marco Grasso, Alessandro Vitale, Enrico Pizzirani, Giulio Barbiero, Alberto Zanetto, Paolo Feltracco, Paolo Simioni, Patrizia Burra, Umberto Cillo. Role of nonneoplastic PVT in the natural history of patients with cirrhosis and first diagnosis of HCC. Hepatology 2024; 79(2): 355 doi: 10.1097/HEP.0000000000000538
|
| 12 |
AngioJet-assisted transvenous-transhepatic mechanical thrombectomy in the portal vein. Polish Journal of Radiology 2018; 83: 619 doi: 10.5114/pjr.2018.81380
|
| 13 |
Dominique C. Valla. Recent developments in the field of vascular liver diseases. Liver International 2020; 40(S1): 142 doi: 10.1111/liv.14348
|
| 14 |
|
| 15 |
Andrea Mancuso, Mario Mitra, Alberto Maringhini. Treatment of portal vein thrombosis in cirrhosis: is it really needed?. European Journal of Gastroenterology & Hepatology 2018; 30(8): 901 doi: 10.1097/MEG.0000000000001119
|
| 16 |
Ying Li, Jing Gao, Xubin Zheng, Guole Nie, Jican Qin, Haiping Wang, Tao He, Åsa Wheelock, Chuan-Xing Li, Lixin Cheng, Xun Li. Diagnostic Prediction of portal vein thrombosis in chronic cirrhosis patients using data-driven precision medicine model. Briefings in Bioinformatics 2023; 25(1) doi: 10.1093/bib/bbad478
|
| 17 |
Mariella Faccia, Maria Elena Ainora, Francesca Romana Ponziani, Laura Riccardi, Matteo Garcovich, Antonio Gasbarrini, Maurizio Pompili, Maria Assunta Zocco. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World Journal of Gastroenterology 2019; 25(31): 4437-4451 doi: 10.3748/wjg.v25.i31.4437
|
| 18 |
Lauren Kasmikha, Naoshin Khan, Mohamed Ramzi Almajed, Abigail Entz, Syed-Mohammed Jafri. Hepatitis C Cirrhosis, Hepatitis B Superimposed Infection, and the Emergence of an Acute Portal Vein Thrombosis: A Case Report. Cureus 2023; doi: 10.7759/cureus.39839
|
| 19 |
Andrea Mancuso. Anticoagulation for Portal Vein Thrombosis in Cirrhosis. American Journal of Gastroenterology 2019; 114(6): 1000 doi: 10.14309/ajg.0000000000000158
|
| 20 |
Guole Nie, Honglong Zhang, Wei Luo, Xingwang Zhu, Danna Xie, Jun Yan, Haiping Wang, Xun Li. Enhancement of endothelial function and attenuation of portal vein injury using mesenchymal stem cells carrying miRNA-25-3p. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64263-6
|
| 21 |
Xiaowen Fan, Xiaoquan Huang, Melissa Hershman, Xin Zheng, Changchuan Jiang, Bing Yue, Ilan Weisberg. Portal vein thrombosis prevalence and mortality among alcoholic cirrhosis in a nationwide inpatient cohort. European Journal of Gastroenterology & Hepatology 2020; 32(9): 1160 doi: 10.1097/MEG.0000000000001624
|
| 22 |
Eliabe Silva de Abreu, Mateus Jorge Nardelli, André Mourão Costa Lima, Jaqueline Brito Cardoso, Fernanda Maria Farage Osório, Teresa Cristina de Abreu Ferrari, Luciana Costa Faria, Cláudia Alves Couto, Guilherme Grossi Lopes Cançado. Carvedilol as secondary prophylaxis for variceal bleeding in hepatosplenic schistosomiasis. Transactions of The Royal Society of Tropical Medicine and Hygiene 2022; 116(7): 663 doi: 10.1093/trstmh/trab190
|
| 23 |
Jonathan G. Stine, Patrick G. Northup. Coagulopathy Before and After Liver Transplantation. Clinics in Liver Disease 2017; 21(2): 253 doi: 10.1016/j.cld.2016.12.003
|
| 24 |
|
| 25 |
Le Wang, Xiaozhong Guo, Xiangbo Xu, Cyriac Abby Philips, Massimo Primignani, Nahum Mendez-Sanchez, Qianqian Li, Kexin Zheng, Xingshun Qi. Association of portal venous system thrombosis with endoscopic variceal treatment: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2021; 32(2): 125 doi: 10.1097/MEG.0000000000001774
|
| 26 |
Steven D. Ma, Jennifer Wang, Dmitri Bezinover, Zakiyah Kadry, Patrick G. Northup, Jonathan G. Stine. Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta‐analysis. Research and Practice in Thrombosis and Haemostasis 2019; 3(4): 658 doi: 10.1002/rth2.12253
|
| 27 |
Andrea Mancuso. Controversies in the Management of Portal Vein Thrombosis in Liver Cirrhosis. Journal of Clinical Medicine 2020; 9(12): 3916 doi: 10.3390/jcm9123916
|
| 28 |
A. Dhaliwal, M. J. Armstrong, D. Tripathi. Patient Selection for Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion in Variceal Bleeding and Refractory Ascites. Current Hepatology Reports 2017; 16(3): 241 doi: 10.1007/s11901-017-0361-y
|
| 29 |
Ellen G. Driever, Fien A. von Meijenfeldt, Jelle Adelmeijer, Robbert J. de Haas, Marius C. van den Heuvel, Chandrasekaran Nagasami, John W. Weisel, Constantino Fondevila, Robert J. Porte, Anabel Blasi, Nigel Heaton, Stephen Gregory, Pauline Kane, William Bernal, Yoh Zen, Ton Lisman. Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus. Hepatology 2022; 75(4): 898 doi: 10.1002/hep.32169
|
| 30 |
Andrea Mancuso, Flavia Politi, Alberto Maringhini. Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?. Gastroenterology 2018; 154(3): 758 doi: 10.1053/j.gastro.2017.07.053
|
| 31 |
Fuat H. Saner, Ecaterina Scarlatescu, Dieter Clemens Broering, Dmitri Bezinover. The Yin and the Yang of Hemostasis in End-Stage Liver Disease. Journal of Clinical Medicine 2023; 12(17): 5759 doi: 10.3390/jcm12175759
|
| 32 |
Tanuja Manohar, Anurag Lavekar, Dhananjay Raje, Aarsha Sadar, Kavutharapu Sri Manjari, Pradeep T Satyanarayana. Predictors of Three-month Hospital Readmissions and Mortality in Patients with Cirrhosis of Liver
. Euroasian Journal of Hepato-Gastroenterology 2019; 9(2): 71 doi: 10.5005/jp-journals-10018-1302
|
| 33 |
Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). Journal of Digestive Diseases 2021; 22(4): 176 doi: 10.1111/1751-2980.12970
|
| 34 |
Jessica P. E. Davis, Amy G. Ogurick, Carrie E. Rothermel, Min-Woong Sohn, Nicolas M. Intagliata, Patrick G. Northup. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunting for Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis 2019; 25 doi: 10.1177/1076029619888026
|
| 35 |
Justin A Steggerda, Krishnaraj Mahendraraj, Tsuyoshi Todo, Mazen Noureddin. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. World Journal of Gastroenterology 2020; 26(28): 4018-4035 doi: 10.3748/wjg.v26.i28.4018
|
| 36 |
Hajime Takatori, Takehiro Hayashi, Hidetoshi Nakagawa, Shuichi Kaneko. Portal Vein Thrombosis. 2021; : 77 doi: 10.1007/978-981-33-6538-4_6
|
| 37 |
Yali Shi, Wanlin Feng, Jiaman Cai, Zhonglin Wang, Ying Pu, Weiting Mao, Ke Zhan, Daorong Chen. Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03322-8
|
| 38 |
Andrea Mancuso. The ischemic liver cirrhosis theory and its clinical implications. Medical Hypotheses 2016; 94: 4 doi: 10.1016/j.mehy.2016.06.008
|
| 39 |
Georgios N. Kalambokis, Aikaterini Oikonomou, Leonidas Christou, Nikolaos I. Kolaitis, Epameinondas V. Tsianos, Dimitrios Christodoulou, Gerasimos Baltayiannis. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia. Journal of Hepatology 2016; 65(5): 921 doi: 10.1016/j.jhep.2016.06.002
|
| 40 |
Takehiro Hayashi, Hajime Takatori, Rika Horii, Kouki Nio, Takeshi Terashima, Noriho Iida, Masaaki Kitahara, Tetsuro Shimakami, Kuniaki Arai, Kazuya Kitamura, Kazunori Kawaguchi, Taro Yamashita, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Tadashi Toyama, Kenichiro Okumura, Kazuto Kozaka, Shuichi Kaneko. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1140-8
|
| 41 |
Gloriany Rivas, Breianna Hummer-Bair, Dmitri Bezinover, Zakiyah Kadry, Jonathan Stine. Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis. BMJ Open Gastroenterology 2021; 8(1): e000683 doi: 10.1136/bmjgast-2021-000683
|
| 42 |
Aina Anton, Genís Campreciós, Valeria Pérez-Campuzano, Lara Orts, Joan Carles García-Pagán, Virginia Hernández-Gea. The Pathophysiology of Portal Vein Thrombosis in Cirrhosis: Getting Deeper into Virchow’s Triad. Journal of Clinical Medicine 2022; 11(3): 800 doi: 10.3390/jcm11030800
|
| 43 |
Dina Mansour, Steven Masson, John Hammond, Joanna A Leithead, Jill Johnson, Mussarat Nazia Rahim, Andrew C Douds, Lynsey Corless, Debbie L Shawcross, Michael A Heneghan, Dhiraj Tripathi, Stuart McPherson, Emily Bonner, Gemma Botterill, Rebecca West, Mhairi Donnelly, Allison Grapes, Coral Hollywood, Valerie Ross. British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 3: special circumstances. Frontline Gastroenterology 2023; 14(6): 474 doi: 10.1136/flgastro-2023-102432
|
| 44 |
Jonathan G. Stine, Curtis K. Argo, Shawn J. Pelletier, Daniel G. Maluf, Patrick G. Northup. Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis. Transplant International 2016; 29(12): 1286 doi: 10.1111/tri.12855
|
| 45 |
Anita Rajasekhar, Marc Zumberg. Consultative Hemostasis and Thrombosis. 2019; : 300 doi: 10.1016/B978-0-323-46202-0.00017-0
|
| 46 |
Dominique‐Charles Valla. Schiff's Diseases of the Liver. 2017; : 909 doi: 10.1002/9781119251316.ch33
|
| 47 |
Shiv K. Sarin, Ashok Choudhury, Cyriac A. Philips, Patrick Kamath, Hitoshi Maruyama, Dominique Valla. Reply. Gastroenterology 2017; 152(5): 1247 doi: 10.1053/j.gastro.2017.03.003
|
| 48 |
Jonathan G. Stine, Shaurya Prakash, Patrick G. Northup. Portal vein thrombosis after hepatitis C eradication with direct acting antiviral therapy. Liver International 2018; 38(1): 185 doi: 10.1111/liv.13537
|
| 49 |
Francesco Violi, Lorenzo Loffredo, Daniele Pastori. Anticoagulation in patients with advanced liver disease: an open issue. Internal and Emergency Medicine 2021; 16(1): 61 doi: 10.1007/s11739-020-02526-6
|
| 50 |
Nicolas M. Intagliata, Perica Davitkov, Alina M. Allen, Yngve T. Falck-Ytter, Jonathan G. Stine. AGA Technical Review on Coagulation in Cirrhosis. Gastroenterology 2021; 161(5): 1630 doi: 10.1053/j.gastro.2021.09.004
|
| 51 |
Lara N. Roberts, Virginia Hernandez‐Gea, Maria Magnusson, Simon Stanworth, Jecko Thachil, Armando Tripodi, Ton Lisman. Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis 2022; 20(10): 2237 doi: 10.1111/jth.15829
|
| 52 |
Andrea Mancuso. Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation. Current Hepatology Reports 2017; 16(2): 158 doi: 10.1007/s11901-017-0344-z
|
| 53 |
Zhinian Wu, Ying Xiao, Yadong Wang. Portal vein thrombosis in liver cirrhosis: An updated overview. Portal Hypertension & Cirrhosis 2023; 2(2): 78 doi: 10.1002/poh2.46
|
| 54 |
Ting-Ting Jiang, Xiao-Ping Luo, Jian-Ming Sun, Jian Gao. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy <i>vs</i> transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis. World Journal of Gastroenterology 2017; 23(41): 7470-7477 doi: 10.3748/wjg.v23.i41.7470
|
| 55 |
Jing Zhao, Jian-Ru Li, Ai-Jun Zhang, Xiao-Lei Li, Jian Liang, Ai-Ping Zheng. Relationship between portal vein width and portal vein thrombosis in patients with hepatitis B cirrhosis. World Chinese Journal of Digestology 2022; 30(1): 24 doi: 10.11569/wcjd.v30.i1.24
|
| 56 |
Jessica P. E. Davis, Nicolas M. Intagliata. The Critically Ill Cirrhotic Patient. 2020; : 219 doi: 10.1007/978-3-030-24490-3_12
|
| 57 |
Stefania Basili, Roberto Carnevale, Cristina Nocella, Simona Bartimoccia, Valeria Raparelli, Giovanni Talerico, Lucia Stefanini, Giulio F. Romiti, Francesco Perticone, Gino R. Corazza, Fabio Piscaglia, Antonello Pietrangelo, Francesco Violi. Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis. Hepatology Communications 2019; 3(4): 504 doi: 10.1002/hep4.1317
|
| 58 |
Michael Loudin, Joseph Ahn. Portal Vein Thrombosis in Cirrhosis. Journal of Clinical Gastroenterology 2017; 51(7): 579 doi: 10.1097/MCG.0000000000000834
|
| 59 |
Jian Wang, Jia-Sui Chai, Ya-Min Zhang. Anticoagulation treatment of portal vein thrombosis in a patient with cirrhosis awaiting liver transplantation. Medicine 2018; 97(26): e11183 doi: 10.1097/MD.0000000000011183
|
| 60 |
Marco Biolato, Mattia Paratore, Luca Di Gialleonardo, Giuseppe Marrone, Antonio Grieco. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?. World Journal of Hepatology 2022; 14(4): 682-695 doi: 10.4254/wjh.v14.i4.682
|
| 61 |
Andrea Mancuso. Management of portal vein thrombosis in cirrhosis: an update. European Journal of Gastroenterology & Hepatology 2016; 28(7): 739 doi: 10.1097/MEG.0000000000000633
|
| 62 |
Ho Soo Chun, A Reum Choe, Minjong Lee, Yuri Cho, Hwi Young Kim, Kwon Yoo, Tae Hun Kim. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis. Clinical and Molecular Hepatology 2021; 27(4): 535 doi: 10.3350/cmh.2021.0109
|
| 63 |
Guilherme G L Cançado, Mateus J Nardelli, Fernanda A Barbosa, Catherine F Silva, Fernanda M F Osório, Teresa C A Ferrari, Claudia A Couto, Luciana C Faria. Portal vein thrombosis in patients with hepatosplenic schistosomiasis who underwent oesophagogastric devascularization combined with splenectomy. Transactions of The Royal Society of Tropical Medicine and Hygiene 2021; 115(9): 1004 doi: 10.1093/trstmh/trab013
|
| 64 |
Manus Rugivarodom, Phunchai Charatcharoenwitthaya. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis. Journal of Clinical and Translational Hepatology 2020; 9(1): 1 doi: 10.14218/JCTH.2020.00067
|
| 65 |
Yanan Guo, Sisi Dong, Meng Li, Yanyan Tao, Jing Lv, Chenghai Liu. A new model of portal vein thrombosis in rats with cirrhosis induced by partial portal vein ligation plus carbon tetrachloride and intervened with rivaroxaban. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03253-4
|
| 66 |
Tsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, Rika Horii, Kouki Nio, Takeshi Terashima, Noriho Iida, Masaaki Kitahara, Tetsuro Shimakami, Kuniaki Arai, Taro Yamashita, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Kenichiro Okumura, Kazuto Kozaka, Shuichi Kaneko. Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis. Life 2020; 10(9): 177 doi: 10.3390/life10090177
|
| 67 |
S. E. Voskanyan, A. I. Artemiev, E. V. Naidenov, K. K. Gubarev, I. Yu. Kolyshev, V. S. Rudakov, D. A. Zabezhinsky, A. N. Bashkov, A. I. Sushkov, M. V. Popov, M. M. Fozilov, D. S. Svetlakova, A. P. Maltseva. Liver transplantation for cirrhosis complicated by non-tumor thrombosis of mesenteric portal system. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2022; 27(4): 71 doi: 10.16931/1995-5464.2022-4-71-83
|
| 68 |
Simone Di Cola, Lucia Lapenna, Jakub Gazda, Stefano Fonte, Giulia Cusi, Samuele Esposito, Marco Mattana, Manuela Merli. Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting. Journal of Clinical Medicine 2024; 13(2): 600 doi: 10.3390/jcm13020600
|
| 69 |
Ikejiri Makoto, Masanobu Usui, Hideo Wada, Takeshi Matsumoto, Kohshi Ohishi, Akihiro Shindo, Yoshiki Yamashita, Kaname Nakatani, Shigehisa Tamaki, Hidekazu Tomimoto, Shuji Isaji. Congenital Thrombophilia in Patients With Superior Mesenteric Venous Thrombosis or Portal Vein Thrombosis. Clinical and Applied Thrombosis/Hemostasis 2018; 24(7): 1117 doi: 10.1177/1076029618774146
|
| 70 |
Michael Schultheiß, Dominik Bettinger, Robert Thimme, Martin Rössle. 30 Jahre transjugulärer intrahepatischer portosystemischer Shunt (TIPS) – Rückblick und Perspektive. Zeitschrift für Gastroenterologie 2020; 58(09): 877 doi: 10.1055/a-1217-7866
|
| 71 |
Emanuele Valeriani, Marcello Di Nisio, Nicoletta Riva, Omri Cohen, Ettore Porreca, Marco Senzolo, Andrea De Gottardi, Marta Magaz, Juan-Carlos Garcia-Pagan, Walter Ageno. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Thrombosis and Haemostasis 2021; 121(07): 867 doi: 10.1055/s-0040-1722192
|
| 72 |
Andrea Mancuso. Management of portal vein thrombosis in cirrhosis: More shadows than lights. Digestive and Liver Disease 2017; 49(2): 228 doi: 10.1016/j.dld.2016.03.012
|
| 73 |
Chunwei Cheng, Juan Hua, Liang Xiong. Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin in Cirrhotic Patients: A Systematic Review and Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis 2024; 30 doi: 10.1177/10760296241301402
|
| 74 |
Jian-Bin Zhang, Jie Chen, Jin Zhou, Xu-Ming Wang, Shu Chen, Jian-Guo Chu, Peng Liu, Zhi-Dong Ye. Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis. World Journal of Clinical Cases 2021; 9(19): 5179-5190 doi: 10.12998/wjcc.v9.i19.5179
|
| 75 |
业群 贺. Research Progress on Risk Factors of Portal Vein Thrombosis in Cirrhosis. Advances in Clinical Medicine 2022; 12(01): 633 doi: 10.12677/ACM.2022.121094
|
| 76 |
Ayako Sato, Sho Watanabe, Mari Iseki, Yurina Yamada, Ryohei Kobayashi, Makoto Furuya, Katsuhiro Arai, Eri Ohshina, Yoshihiro Tashiro, Takahito Nozaka, Mana Matsuoka, Masato Yauchi, Katsumasa Kobayashi, Taichi Matsumoto, Yohei Furumoto, Toru Asano, Seishin Azuma. Anticoagulation against portal vein thrombosis reduces mortality and liver cirrhosis‐related complications: A propensity score‐matched study. Hepatology Research 2023; 53(11): 1096 doi: 10.1111/hepr.13942
|
| 77 |
T. Lisman, S. Bos, N.M. Intagliata. Mechanisms of enhanced thrombin‐generating capacity in patients with cirrhosis. Journal of Thrombosis and Haemostasis 2018; 16(6): 1128 doi: 10.1111/jth.14020
|
| 78 |
Bihui Zhang, Ziping Yao, Pengyu Li, Guochen Niu, Ziguang Yan, Kang She, Gong Cheng, Min Yang. Causal Relationships of Circulating Inflammatory Proteins and Portal Vein Thrombosis: A Mendelian Randomization Study. Seminars in Thrombosis and Hemostasis 2024; doi: 10.1055/s-0044-1790259
|
| 79 |
Brandon G. Mui, Lauren T. Grinspan, James F. Crismale. Variations in Practice Among Cirrhotic Patients With Portal Vein Thrombosis and Esophageal Varices: A North American Survey Study. American Journal of Gastroenterology 2024; doi: 10.14309/ajg.0000000000002640
|
| 80 |
芯 雷. Treatment of Liver Cirrhosis with PVT. Advances in Clinical Medicine 2021; 11(07): 2920 doi: 10.12677/ACM.2021.117423
|
| 81 |
Vlad Damian Vintilă, Alexandra Maria Chitroceanu, Ana-Maria Vintilă. Liver Diseases. 2020; : 117 doi: 10.1007/978-3-030-24432-3_11
|
| 82 |
Le Wang, Xiaozhong Guo, Xiangbo Xu, Valerio De Stefano, Aurelie Plessier, Carlos Noronha Ferreira, Xingshun Qi. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis. Advances in Therapy 2021; 38(1): 495 doi: 10.1007/s12325-020-01550-4
|
| 83 |
Kryssia I. Rodriguez-Castro, Alessandro Vitale, Mariangela Fadin, Sarah Shalaby, Patrizia Zerbinati, Maria Teresa Sartori, Stefano Landi, Irene Pettinari, Fabio Piscaglia, Guohong Han, Patrizia Burra, Paolo Simioni, Marco Senzolo. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis. European Journal of Gastroenterology & Hepatology 2019; 31(1): 34 doi: 10.1097/MEG.0000000000001237
|
| 84 |
Adonis A. Protopapas, Christos Savopoulos, Lemonia Skoura, Ioannis Goulis. Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?. Digestive Diseases and Sciences 2023; 68(6): 2237 doi: 10.1007/s10620-023-07858-9
|
| 85 |
Thomas A. Verbeek, Jonathan G. Stine, Fuat H. Saner, Dmitri Bezinover. Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management. Transplantation Direct 2018; 4(11): e403 doi: 10.1097/TXD.0000000000000843
|
| 86 |
Michel Bergère, Domitille Erard-Poinsot, Olivier Boillot, Pierre-Jean Valette, Olivier Guillaud, Christine Chambon-Augoyard, Jérôme Dumortier. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe. Clinics and Research in Hepatology and Gastroenterology 2019; 43(4): 395 doi: 10.1016/j.clinre.2018.11.011
|
| 87 |
Nicolas M. Intagliata, Stephen H. Caldwell, Armando Tripodi. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019; 156(6): 1582 doi: 10.1053/j.gastro.2019.01.265
|
| 88 |
Ting Zhou, Xin Sun, Tao Zhou, Yueyue Li, Xiaoning Chen, Baoquan Cheng, Yanjing Gao. Efficacy and Safety of Nadroparin Calcium-Warfarin Sequential Anticoagulation in Portal Vein Thrombosis in Cirrhotic Patients: A Randomized Controlled Trial. Clinical and Translational Gastroenterology 2020; 11(9): e00228 doi: 10.14309/ctg.0000000000000228
|
| 89 |
Shuai Xue, Peisong Wang, Hui Han, Guang Chen. Management of Chronic Liver Diseases - Recent Advances. 2018; doi: 10.5772/intechopen.76295
|
| 90 |
Dominique‐Charles Valla. Sherlock's Diseases of the Liver and Biliary System. 2018; : 209 doi: 10.1002/9781119237662.ch12
|
| 91 |
Aaron Liew, James Douketis. Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?. Internal and Emergency Medicine 2016; 11(8): 1037 doi: 10.1007/s11739-016-1463-1
|
| 92 |
Tomás Artaza, Miriam Lopes, Marta Romero, Juan José Sánchez, Gema De la Cruz, Concepción González, Rafael Gómez. Non-Malignant Portal Vein Thrombosis in Liver Cirrhosis: Diagnosis and Treatment. EMJ Hepatology 2016; : 103 doi: 10.33590/emjhepatol/10311905
|
| 93 |
Jonathan G. Stine, Ian Schreibman, Seyedehsan Navabi, Mitchell Kang, Jessica Dahmus, Christopher Soriano, Gloriany Rivas, Breianna Hummer, Megan Beyer, Heather Tressler, Scot R. Kimball, Andrew D. Patterson, Kathryn Schmitz, Christopher Sciamanna. Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH. Contemporary Clinical Trials Communications 2020; 18: 100560 doi: 10.1016/j.conctc.2020.100560
|
| 94 |
Jian-Bo Han, Qing-Hua Shu, Yu-Feng Zhang, Yong-Xiang Yi. Predictive Value of Inflammation Biomarkers in Patients with Portal Vein Thrombosis. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00159
|
| 95 |
Zeljka Savic, Dimitrije Damjanov, Olgica Latinovic-Bosnjak, Nebojsa Janjic, Bozidar Dejanovic, Zarko Krnetic, Vladimir Vracaric. Portal vein thrombosis in patients with liver cirrhosis. Vojnosanitetski pregled 2024; 81(6): 368 doi: 10.2298/VSP240116029S
|
| 96 |
A. V. Yagoda, P. V. Koroy, L. S. Baisaeva, T. R. Dudov. Portal Vein Thrombosis in Liver Cirrhosis. Part 1: Epidemiology, Pathogenesis, Clinic, Diag-nosis, Impact on Prognosis. The Russian Archives of Internal Medicine 2024; 14(3): 165 doi: 10.20514/2226-6704-2024-14-3-165-172
|
| 97 |
Jonathan G. Stine, Patrick G. Northup. Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis. Digestive Diseases and Sciences 2019; 64(3): 619 doi: 10.1007/s10620-018-5427-3
|
| 98 |
Andrea Mancuso. Classification of Portal Vein Thrombosis in Cirrhosis. Gastroenterology 2017; 152(5): 1247 doi: 10.1053/j.gastro.2016.09.067
|
| 99 |
Thomas G. Cotter, Anjana A. Pillai. Consult for Portal Vein Thrombosis. Clinical Liver Disease 2019; 14(2): 74 doi: 10.1002/cld.748
|
| 100 |
Jianchun Xian, Yongzhi Tang, Hui Shao, Xuequan Wang, Meixian Zhang, Tongjing Xing. Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant. Medicine 2021; 100(16): e25439 doi: 10.1097/MD.0000000000025439
|